DD131762A5 - Verfahren zur herstellung eines pferde-rhinopneumonievakzins - Google Patents

Verfahren zur herstellung eines pferde-rhinopneumonievakzins

Info

Publication number
DD131762A5
DD131762A5 DD7700198562A DD19856277A DD131762A5 DD 131762 A5 DD131762 A5 DD 131762A5 DD 7700198562 A DD7700198562 A DD 7700198562A DD 19856277 A DD19856277 A DD 19856277A DD 131762 A5 DD131762 A5 DD 131762A5
Authority
DD
German Democratic Republic
Prior art keywords
rhinopneumonia
vaccine
horse
producing
rhinopneumonia vaccine
Prior art date
Application number
DD7700198562A
Other languages
German (de)
English (en)
Inventor
Charles W Purdy
Original Assignee
Philips Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philips Nv filed Critical Philips Nv
Publication of DD131762A5 publication Critical patent/DD131762A5/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/27—Equine rhinopneumonitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16761—Methods of inactivation or attenuation
    • C12N2710/16764—Methods of inactivation or attenuation by serial passage
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/82—Viral vaccine for equine species, e.g. horses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DD7700198562A 1976-04-23 1977-04-22 Verfahren zur herstellung eines pferde-rhinopneumonievakzins DD131762A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/679,840 US4110433A (en) 1976-04-23 1976-04-23 Equine rhinopneumonitis virus

Publications (1)

Publication Number Publication Date
DD131762A5 true DD131762A5 (de) 1978-07-19

Family

ID=24728588

Family Applications (1)

Application Number Title Priority Date Filing Date
DD7700198562A DD131762A5 (de) 1976-04-23 1977-04-22 Verfahren zur herstellung eines pferde-rhinopneumonievakzins

Country Status (14)

Country Link
US (1) US4110433A (enExample)
AU (1) AU2454077A (enExample)
BE (1) BE853810A (enExample)
DD (1) DD131762A5 (enExample)
DE (1) DE2717919A1 (enExample)
ES (1) ES458113A1 (enExample)
FR (1) FR2348704A1 (enExample)
GB (1) GB1570732A (enExample)
LU (1) LU77166A1 (enExample)
NL (1) NL7704239A (enExample)
NZ (1) NZ183907A (enExample)
PL (1) PL197579A1 (enExample)
SE (1) SE7704514L (enExample)
SU (1) SU700069A3 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4225582A (en) * 1979-03-08 1980-09-30 The University Of Illinois Foundation Vaccine for equine rhinopneumonitis
US4636469A (en) * 1982-04-07 1987-01-13 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Isolation of hepatitis A virus strain HM-175
US4532215A (en) * 1982-04-07 1985-07-30 The United States Of America As Represented By The Department Of Health And Human Services Isolation of hepatitis A virus strain HM-175
NZ224422A (en) * 1987-05-05 1990-11-27 Molecular Eng Ass Composition adapted for intranasal immunisation against viral infection comprising a glycoprotein complexed with a lipid
US5192539A (en) * 1988-07-21 1993-03-09 Akzo N.V. Infectious bursal disease virus production in continuous cell lines
AU8545391A (en) * 1990-08-01 1992-03-02 Research Corporation Technologies, Inc. The gene encoding equine herpesvirus type 1 glycoprotein d, its gene product, antibodies and their uses
ZA97452B (en) * 1996-01-25 1997-08-15 Trinity College Dublin Streptococcus equi vaccine.
US5853715A (en) * 1996-08-16 1998-12-29 Bayer Corporation Cross-protective equine herpesvirus preparations and method of making and using the same
CA2243730C (en) * 1997-07-29 2009-12-22 Akzo Nobel N.V. Streptococcus equi vaccine
MXPA02002566A (es) * 1999-09-10 2002-10-23 Akzo Nobel Nv Mutante del virus de herpes equino sensible a la temperatura y vacuna viva del mismo.
US7678087B2 (en) * 1999-09-29 2010-03-16 Heska Corporation Equine intranasal delivery system
US6398774B1 (en) 1999-09-29 2002-06-04 Heska Corporation Intranasal delivery system
US6803041B2 (en) * 2001-03-20 2004-10-12 Boehringer Ingelheim Vetmedica, Inc. Equine herpesvirus vaccine
AU2007233252C1 (en) 2006-03-29 2013-05-23 Boehringer Ingelheim Animal Health USA Inc. Vaccine against Streptococci
CN114214289A (zh) * 2021-12-24 2022-03-22 山东省农业科学院畜牧兽医研究所 一株马冠状病毒ECoV464693及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1692043C3 (de) * 1968-03-06 1979-04-12 Behringwerke Ag, 3550 Marburg Rhinopneumonitis-Vaccine und Verfahren zu deren Herstellung

Also Published As

Publication number Publication date
SU700069A3 (ru) 1979-11-25
ES458113A1 (es) 1978-03-16
AU2454077A (en) 1978-10-26
SE7704514L (sv) 1977-10-24
BE853810A (fr) 1977-10-21
NL7704239A (nl) 1977-10-25
US4110433A (en) 1978-08-29
PL197579A1 (pl) 1978-09-25
LU77166A1 (enExample) 1977-08-12
NZ183907A (en) 1979-10-25
DE2717919A1 (de) 1977-11-03
FR2348704A1 (fr) 1977-11-18
GB1570732A (en) 1980-07-09

Similar Documents

Publication Publication Date Title
DD133519A5 (de) Verfahren zur herstellung eines stuetzverbands
AT376503B (de) Verfahren zur herstellung eines retroreflektierenden bahnenmaterials
AT355238B (de) Verfahren zur herstellung eines neuen hentriakontapeptids
DD132052A5 (de) Verfahren zur herstellung eines katalysators
AT355523B (de) Verfahren zur herstellung eines gurtbandes
AT363351B (de) Verfahren zur herstellung eines seils
DD132786A5 (de) Verfahren zur herstellung eines neuen oximaethers
AT370397B (de) Verfahren zur herstellung eines leichtbaustoffes
DD131762A5 (de) Verfahren zur herstellung eines pferde-rhinopneumonievakzins
AT357407B (de) Verfahren zur herstellung eines speckaehnlichen produktes
AT360512B (de) Verfahren zur herstellung eines d-enantiomeren indolderivats
AT362496B (de) Verfahren zur herstellung einer tollwut-vaccine
ATA499079A (de) Verfahren zur herstellung eines synthetischen crepegarns
AT358792B (de) Verfahren zur herstellung eines doppelbodens
AT366056B (de) Verfahren zur herstellung eines phosphordichloridothiolats
AT358723B (de) Verfahren zur herstellung eines lipasereichen enzympraeparates
AT362214B (de) Verfahren zur herstellung eines schichtstoffes
AT362055B (de) Verfahren zur herstellung eines stabilen baldrianextraktpraeparates
AT367071B (de) Verfahren zur herstellung eines katalysators
AT357855B (de) Verfahren zur herstellung eines pektin- praeparates
AT361527B (de) Verfahren zur herstellung eines verbundwerk- stoffes
DD133672A5 (de) Verfahren zur herstellung eines saeureadditionssalzes
AT372469B (de) Verfahren zur herstellung eines zementgebundenen estrichs
AT365615B (de) Verfahren zur herstellung eines latex
ATA366280A (de) Verfahren zur herstellung eines polyurethangels